Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.
Exactech makes orthopedic implant devices and related surgical instruments that it markets to hospitals and doctors. Aging baby boomers are increasing the number of orthopedic procedures done every year, and private equity manager TPG thinks it can accelerate market share over time by owning the company outright.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Johnson & Johnson Aktie
Reines Buy-Sentiment für Johnson & Johnson, keine Sell-Einschätzungen in Sicht.
Für Johnson & Johnson sieht die Community ein leicht positives Kursziel von 227 €, verglichen mit dem aktuellen Kurs von 224.25 €.


